Menstrual Migraine in the Acute Attack Phase
Menstrual Migraine
Menstrual migraine, also said “catamenial”, is a form of primary headache that affects women of childbearing age in close relationship with the menstrual cycle. According to the diagnostic criteria of the International Headache Society (ICHD-3), it is defined as pure menstrual migraine when the attacks occur exclusively in a specific time window of the cycle, while talking about menstruation-related migraine when the attacks appear both in that period and in other phases of the cycle.
Diagnostic criteria
To make a diagnosis, two criteria must be met:
It is important to distinguish menstrual migraine from “tensive headache”, generally of milder-moderate intensity, with bilateral constricting pain; migraine without aura, characterized by pulsating pain, often unilateral, associated with nausea and / or photophobia; Migraine with aura, more complex, preceded or accompanied by transient neurological symptoms (visual, sensory, or language symptoms).
The main predisposing factor recognized is the drop in estrogeneic levels that precedes the onset of menstruation. The abrupt reduction of estrogen seems to modulate the neurovascular and neurotransmitter systems involved in the genesis of migraine, in particular the serotonergic and trigeminovascular circuits.
How can AuraSTOP help?
Nutraceutical integration
In the most mild-moderate forms, in particular when the migraine attack is preceded by perimstrual syndrome, the use of specific food supplements can be considered, to be taken exclusively in the perimenstrual period.
The use of nutraceuticals such as magnesium, riboflavin and feverfew is supported by evidence of episodic migraine, as reported in the recommendations of the European Headache Federation (Sacco et al., 2019) and in Reviews dedicated to the management of menstrual migraines (Macgregor, 2017).
Other approaches, continuous drug prophylaxis
If the attacks are frequent, prolonged or highly disabling, a structured preventive therapy is indicated. The guidelines of the European Headache Federation of 2019 and the 2018 International Headache Society indicate among the first-line drugs:
These molecules are used both in episodic and chronic forms, with specialist indication and monitoring at headache centers.
Hormonal contraception in an extended regime
In patients with menstrual migraine without aura, the administration of combined hormonal contraceptives in continuous or extended regimes (pill, patch or ring, without pauses and without menstruation) may be considered, with the aim of reducing the frequency of the cycle. Reducing the frequency of menstruation leads to a parallel reduction of catamenial attacks. The use of extended contraception regimens has been approved by the Food and Drug Administration (FDA) for contraception and is supported in clinical studies on the hormonal modulation of migraine.
The information provided on this website is for informational purposes only. They should not be interpreted as therapeutic indications nor attributed to the product healing properties. The use of supplements or natural substances must always be assessed on a case-by-case basis by a doctor or health professional. The information does not replace personalized diagnosis, therapies or medical advice.